pharma · Osteoarthritis · Osteoporosis
Nordic Bioscience
Nordic Bioscience A/S
Nordic Bioscience clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Herlev, DK
- Founded
- 1991
- Employees
- 228
- Programs
- 5
- Drugs
- 10
- Patents
- 0
Nordic Bioscience projects
5 ClinicalTrials.gov programs sponsored by Nordic Bioscience.
Nordic Bioscience has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
SMC021 Oral Calcitonin
Nordic Bioscience A/S
Osteoarthritis
1 trial -
SMC021 Oral calcitonin
Nordic Bioscience A/S
Osteoporosis
1 trial -
CSCI-SKT-B1001
Nordic Bioscience A/S
Atopic dermatitis
1 trial -
Leukine for Ovarian cancer
Nordic Bioscience A/S
Ovarian cancer
1 trial -
Teverelix TFA
Nordic Bioscience A/S
Advanced prostate cancer
1 trial
Frequently asked questions
How many clinical projects does Nordic Bioscience have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.